Interoceptive attention regulation in Ehlers-Danlos syndromes: associations between pain and psychiatric symptom severity.


Journal

Translational behavioral medicine
ISSN: 1613-9860
Titre abrégé: Transl Behav Med
Pays: England
ID NLM: 101554668

Informations de publication

Date de publication:
23 10 2021
Historique:
pubmed: 6 5 2021
medline: 17 3 2022
entrez: 5 5 2021
Statut: ppublish

Résumé

High rates of comorbid chronic pain, anxiety, and mood disorders among individuals with the Ehlers-Danlos syndromes (EDS+) are becoming increasingly recognized, though this complex symptomology remains poorly understood and undertreated. The current project examined whether interoceptive attention regulation is protective against depressive and anxiety symptoms in individuals with suspected EDS+. Data were collected from individuals participating in a transdisciplinary diagnostic visit within an EDS+ specialty consultation clinic. Participants were included in the current analyses (n = 49) if they had complete data on the following measures: the PHQ-8, the GAD-7, the Pain Severity subscale from the West Haven-Yale Multidimensional Pain Inventory, and the Attention Regulation subscale from the Multidimensional Assessment of Interoceptive Awareness. Consistent with expectations, the sample showed high levels of clinically significant anxiety and depressive symptoms. Pain severity ratings were significantly correlated with depressive but not anxiety severity. Moreover, higher levels of perceived interoceptive attention regulation abilities were significantly associated with less severe anxiety and depressive symptoms; however, attention regulation did not moderate the associations of pain with anxiety and depressive symptom severity. The current project replicated recent findings that pain, anxiety, and depression are common in individuals with EDS+. The ability to focus and control somatic attention appears to be protective and a potential target for interventions in EDS+.

Identifiants

pubmed: 33949672
pii: 6265351
doi: 10.1093/tbm/ibab049
pmc: PMC9034325
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1923-1930

Subventions

Organisme : NICHD NIH HHS
ID : K12 HD085852
Pays : United States

Informations de copyright

© Society of Behavioral Medicine 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Philos Trans R Soc Lond B Biol Sci. 2016 Nov 19;371(1708):
pubmed: 28080970
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):5-7
pubmed: 28306227
Auton Neurosci. 2018 Dec;215:46-55
pubmed: 29628432
Rheumatol Int. 2016 Mar;36(3):341-8
pubmed: 26433894
Pain. 1985 Dec;23(4):345-356
pubmed: 4088697
Am Surg. 2013 Jun;79(6):608-13
pubmed: 23711271
Drug Alcohol Depend. 2019 May 1;198:140-149
pubmed: 30928884
Auton Neurosci. 2017 Mar;203:81-87
pubmed: 27865628
Can J Psychiatry. 2008 Apr;53(4):224-34
pubmed: 18478825
Clin Psychol Rev. 2013 Aug;33(6):763-71
pubmed: 23796855
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Behav Res Ther. 2017 Nov;98:39-57
pubmed: 27865431
PLoS One. 2012;7(11):e48230
pubmed: 23133619
Front Psychol. 2015 Jun 09;6:763
pubmed: 26106345
Rehabil Nurs. 2001 Nov-Dec;26(6):216-20, 244
pubmed: 12035721
Disabil Rehabil. 2010;32(1):1-7
pubmed: 19925271
J Clin Psychol. 2018 Apr;74(4):554-565
pubmed: 29076530
Front Psychol. 2014 Oct 14;5:1162
pubmed: 25352818
Psychiatry Res. 2012 Feb 28;195(3):91-106
pubmed: 21705094
West J Nurs Res. 2016 May;38(5):596-628
pubmed: 26604219
Med J Aust. 2009 Apr 6;190(S7):S54-60
pubmed: 19351294
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):237-245
pubmed: 28186381
Am J Med Genet A. 2013 Dec;161A(12):3005-11
pubmed: 23913726
Psychol Med. 2020 Jun;50(8):1368-1380
pubmed: 31298180
BMC Psychiatry. 2017 May 4;17(1):166
pubmed: 28472936
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8-26
pubmed: 28306229
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):159-167
pubmed: 28522289
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852

Auteurs

Madison Niermeyer (M)

Division of Physical Medicine & Rehabilitation, University of Utah, Salt Lake City, UT, USA.

Douglas Ball (D)

Division of Pediatric Genetics, University of Utah, Salt Lake City, UT, USA.

Michael Green (M)

Division of Physical Medicine & Rehabilitation, University of Utah, Salt Lake City, UT, USA.
Clinical Attending at Primary Children's Hospital, Salt Lake City, UT, USA.

Bradley Jensen (B)

Department of Physical Therapy & Athletic Training, University of Utah, Salt Lake City, UT, USA.

Laura Pace (L)

Division of Gastroenterology, University of Utah, Salt Lake City, UT, USA.

Robert Shingleton (R)

Division of Physical Medicine & Rehabilitation, University of Utah, Salt Lake City, UT, USA.

Bradley Fawver (B)

Division of Physical Medicine & Rehabilitation, University of Utah, Salt Lake City, UT, USA.

Stephen K Trapp (SK)

VA Salt Lake City Health Care System, Salt Lake City, UT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH